These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6770126)

  • 21. Comparison of two combined vaccines against typhoid fever and hepatitis A in healthy adults.
    Beeching NJ; Clarke PD; Kitchin NR; Pirmohamed J; Veitch K; Weber F
    Vaccine; 2004 Nov; 23(1):29-35. PubMed ID: 15519704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Characterization of typhoid O and H agglutinins and paratyphoid A and B agglutinins in full-term newborn infants after stimulation with typhoid-paratyphoid vaccine].
    Turbessi G; Ungari S; Aiuti F; Serra GB; Ricci G
    Riv Ist Sieroter Ital; 1966; 41(4):255-63. PubMed ID: 4966014
    [No Abstract]   [Full Text] [Related]  

  • 23. Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination.
    Pakkanen SH; Kantele JM; Kantele A
    Vaccine; 2012 Sep; 30(42):6047-53. PubMed ID: 22858557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Problems of anti-typhoid immunity and protective vaccination against typhoid.
    Karolcek J
    Lek Pr; 1969; 7(1):3-153. PubMed ID: 4917329
    [No Abstract]   [Full Text] [Related]  

  • 25. [Lyophilization of phenolized typhoid vaccine].
    Ruiz Puente J; Alcántara Garzón A; González Pacheco M; Recamier Palacios L
    Salud Publica Mex; 1981; 23(6):649-56. PubMed ID: 6801784
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparative study of the effectiveness of corpuscular and chemical paratyphoid B vaccines in monkey experiments using subcutaneous and parenteral administration.
    Stepanova LK; Gekker VD; Stasilevish ZK; Sergeyeva NS
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(4):386-97. PubMed ID: 4629402
    [No Abstract]   [Full Text] [Related]  

  • 27. [Search for copro-agglutinins in the course of oral TAB vaccination].
    Freni S; Ingiulla M
    Boll Soc Ital Biol Sper; 1968 Dec; 44(23):2093-4. PubMed ID: 4981154
    [No Abstract]   [Full Text] [Related]  

  • 28. Controlled field trials and laboratory studies on the effectiveness of typhoid vaccines in Poland, 1961-64.
    Polish Typhoid Committee
    Bull World Health Organ; 1966; 34(2):211-22. PubMed ID: 5296128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Specific immune responses in typhoid fever & after TAB vaccination.
    Bhaskaram P; Sahay BK; Rao NS
    Indian J Med Res; 1990 Mar; 91():115-9. PubMed ID: 2345018
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative study of the toxicity and immunogenicity of antityphoid vaccines].
    Binsztein N; Cetrangolo R; Eiguer T
    Medicina (B Aires); 1972; 32(5):453-62. PubMed ID: 4649556
    [No Abstract]   [Full Text] [Related]  

  • 31. FIELD and laboratory studies with typhoid vaccines: a preliminary report: Yugoslav Typhoid Commission.
    Yugoslav Typhoid Commission
    Bull World Health Organ; 1957; 16(5):897-910. PubMed ID: 13472436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory research concerning the effectiveness of a typhoid-paratyphoid A and B vaccine administered orally].
    Nestoresco N; Vlădoianu IR; Dimache G; Dimache V; Petruşca J; Bórs A; Constantinesco L
    Arch Roum Pathol Exp Microbiol; 1964 Jun; 23(2):417-22. PubMed ID: 4961444
    [No Abstract]   [Full Text] [Related]  

  • 33. Typhoid vaccine introduction: An evidence-based pilot implementation project in Nepal and Pakistan.
    Khan MI; Pach A; Khan GM; Bajracharya D; Sahastrabuddhe S; Bhutta W; Tahir R; Soofi S; Thapa CB; Joshi N; Puri MK; Shrestha P; Upreti SR; Clemens JD; Bhutta Z; Ochiai RL
    Vaccine; 2015 Jun; 33 Suppl 3():C62-7. PubMed ID: 25937612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rethinking typhoid fever vaccines: implications for travelers and people living in highly endemic areas.
    Whitaker JA; Franco-Paredes C; del Rio C; Edupuganti S
    J Travel Med; 2009; 16(1):46-52. PubMed ID: 19192128
    [No Abstract]   [Full Text] [Related]  

  • 35. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 37. [Is the Widal reaction for typhoid and paratyphoid influenced by the oral intake of larger amounts of killed Salmonella?].
    Finger H; Seeliger H; Schmidt H
    Dtsch Med Wochenschr; 1967 May; 92(19):887-90. PubMed ID: 4960680
    [No Abstract]   [Full Text] [Related]  

  • 38. [Animal experiments on antibody formation following thymectomy in adult rabbits].
    Hempel HC; Grimm J; Schwarz ER; Hofmann K; Korn D
    Dtsch Gesundheitsw; 1969 Jul; 24(28):1304-7. PubMed ID: 4987620
    [No Abstract]   [Full Text] [Related]  

  • 39. New generation typhoid vaccines: an effective preventive strategy to control typhoid fever in developing countries.
    Verma R; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Aug; 7(8):883-5. PubMed ID: 21791973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The preparation, testing and standardization of typhoid vaccine.
    FELIX A
    J Hyg (Lond); 1951; 49(2-3):268-97. PubMed ID: 14880697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.